再鼎医药

Manufacturing · Pharmaceutical Preparations

完成交易日收盘US$21.96+1.36%行情日期 2026-11-03 · 非实时

公开资料页汇总再鼎医药（ZLAB）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。

股价走势

复权收盘价（美元）

2025-10-31 — 2026-11-03253 个交易日样本

查看交易日数据

2026-11-03ZLABUS$21.96

查看图表数据

日期	ZLAB
2025-10-31	26.13
2025-11-03	26.75
2025-11-04	25.89
2025-11-05	24.8
2025-11-06	23.15
2025-11-07	21.9
2025-11-10	21.89
2025-11-11	22
2025-11-12	21.88
2025-11-13	21.73
2025-11-14	21.75
2025-11-17	20.92
2025-11-18	20.48
2025-11-19	20.5
2025-11-20	20.21
2025-11-21	20.02
2025-11-24	19.93
2025-11-25	19.9
2025-11-26	19.97
2025-11-28	20.41
2025-12-01	19.88
2025-12-02	19.52
2025-12-03	19.75
2025-12-04	19.95
2025-12-05	19.5
2025-12-08	19.05
2025-12-09	18.7
2025-12-10	18.28
2025-12-11	17.82
2025-12-12	17.77
2025-12-15	17.34
2025-12-16	17
2025-12-17	17.22
2025-12-18	17.18
2025-12-19	18.04
2025-12-22	17.71
2025-12-23	17.48
2025-12-24	18.58
2025-12-26	18.33
2025-12-29	17.82
2025-12-30	17.63
2025-12-31	17.64
2026-01-02	17.33
2026-01-05	18.09
2026-01-06	18.2
2026-01-07	19.03
2026-01-08	18.5
2026-01-09	18.55
2026-01-12	18.39
2026-01-13	18.72
2026-01-14	19.61
2026-01-15	18.82
2026-01-16	18.58
2026-01-20	18.91
2026-01-21	18.84
2026-01-22	18.37
2026-01-23	18.33
2026-01-26	17.64
2026-01-27	17.05
2026-01-28	17.2
2026-01-29	17.25
2026-01-30	16.6
2026-02-02	16.3
2026-02-03	16.43
2026-02-04	17
2026-02-05	16.98
2026-02-06	18
2026-02-09	18.44
2026-02-10	19.55
2026-02-11	19.03
2026-02-12	18.77
2026-02-13	20.03
2026-02-17	20.04
2026-02-18	20.18
2026-02-19	20.08
2026-02-20	20.04
2026-02-23	19.72
2026-02-24	19.37
2026-02-25	19.39
2026-02-26	19.69
2026-02-27	19.22
2026-03-02	18.42
2026-03-03	17.72
2026-03-04	19.27
2026-03-05	19.3
2026-03-06	19.54
2026-03-09	19.12
2026-03-10	19.46
2026-03-11	19.07
2026-03-12	18.87
2026-03-13	18.37
2026-03-16	19.06
2026-03-17	19.02
2026-03-18	18.83
2026-03-19	18.61
2026-03-20	18.09
2026-03-23	17.61
2026-03-24	17.47
2026-03-25	18.29
2026-03-26	17.51
2026-03-27	18
2026-03-30	17.85
2026-03-31	18.81
2026-04-01	20.34
2026-04-02	20.41
2026-04-06	20.5
2026-04-07	21
2026-04-08	21.39
2026-04-09	20.74
2026-04-10	20.68
2026-04-13	21.34
2026-04-14	21.96
2026-04-15	23.25
2026-04-16	23.5
2026-04-17	24.19
2026-04-20	25.25
2026-04-21	24.44
2026-04-22	22.87
2026-04-23	21.88
2026-04-24	22.77
2026-04-27	21.88
2026-04-28	22.14
2026-04-29	20.75
2026-04-30	21.64
2026-05-01	21.54
2026-05-04	21.22
2026-05-05	20.98
2026-05-06	21.01
2026-05-07	19.77
2026-05-08	18.6
2026-05-11	19.59
2026-05-12	19.53
2026-05-13	20.47
2026-05-14	20.33
2026-05-15	20.59
2026-05-18	18.86
2026-05-19	18.37
2026-05-20	18.81
2026-05-21	19.1
2026-05-22	18.61
2026-05-26	18.45
2026-05-27	18.69
2026-05-28	18.48
2026-05-29	17.69
2026-06-01	17.09
2026-06-02	17.15
2026-06-03	17.17
2026-06-04	17.34
2026-06-05	16.62
2026-06-08	16.48
2026-06-09	16.65
2026-06-10	17.26
2026-06-11	17.64
2026-06-12	17.07
2026-06-15	17.73
2026-06-16	17.73
2026-06-17	17.88
2026-06-18	18.18
2026-06-22	18.48
2026-06-23	18.49
2026-06-24	18.37
2026-06-25	18.52
2026-06-26	18
2026-06-29	18.41
2026-06-30	19
2026-07-01	19.15
2026-07-02	19.12
2026-07-06	19.08
2026-07-07	19.35
2026-07-08	19.75
2026-07-09	19.98
2026-07-10	20.49
2026-07-13	19.62
2026-07-14	19.3
2026-07-15	20.44
2026-07-16	20.75
2026-07-17	20.2
2026-07-20	20.52
2026-07-21	20.48
2026-07-22	20.5
2026-07-23	19.68
2026-07-24	19.22
2026-07-27	18.64
2026-07-28	18.62
2026-07-29	18.31
2026-07-30	18.21
2026-07-31	18.27
2026-08-03	18.18
2026-08-04	18.49
2026-08-05	18.37
2026-08-06	20.88
2026-08-07	23.32
2026-08-10	23.57
2026-08-11	26
2026-08-12	25.49
2026-08-13	26.03
2026-08-14	25.9
2026-08-17	25.64
2026-08-18	25.57
2026-08-19	26.72
2026-08-20	26.02
2026-08-21	26.01
2026-08-24	25.64
2026-08-25	26.17
2026-08-26	26.03
2026-08-27	26.82
2026-08-28	26.08
2026-08-31	25.46
2026-09-01	25.3
2026-09-02	26.48
2026-09-03	27
2026-09-04	26.23
2026-09-08	25.41
2026-09-09	25.08
2026-09-10	24.17
2026-09-11	24.14
2026-09-14	24.58
2026-09-15	24.8
2026-09-16	24.67
2026-09-17	25.81
2026-09-18	25.7
2026-09-21	26.43
2026-09-22	26.41
2026-09-23	26.44
2026-09-24	25.28
2026-09-25	24.98
2026-09-28	25.69
2026-09-29	25.93
2026-09-30	26.34
2026-10-01	25.5
2026-10-02	24.33
2026-10-05	25.62
2026-10-06	25.58
2026-10-07	25.31
2026-10-08	24.81
2026-10-09	24.99
2026-10-12	24.59
2026-10-13	23.1
2026-10-14	22.5
2026-10-15	23.51
2026-10-16	23.19
2026-10-19	24.06
2026-10-20	25.08
2026-10-21	24.2
2026-10-22	22.04
2026-10-23	24.03
2026-10-26	24.34
2026-10-27	23.58
2026-10-28	23.04
2026-10-29	22.36
2026-10-30	22.07
2026-11-02	21.67
2026-11-03	21.96

1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。

使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。

01 · MARKET FRAME

行情、估值与风险

基于已完成交易日和已发布财务资料

市值US$24.6B

市盈率（TTM）—

自由现金流收益率-0.6%

距52周高点-18.7%

近一年波动率+51%

近一年最大回撤-39.1%

区间涨跌幅

10日-12.4%起点 2026-10-20

30日-16.9%起点 2026-09-22

90日+22%起点 2026-06-26

180日+9.6%起点 2026-02-17

250日-15.2%起点 2025-11-04

区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。

02 · FINANCIAL TRACE

财务摘要

公开页仅显示最近3个已校验报告期

年度财务走势

百万美元 · 年度报告期

查看报告期数据

2025-12-31营收457.2百万美元

指标	2026-06-30	2025-12-31	2025-06-30	2024-12-31	2024-06-30	2023-12-31
营收	—	457.2	—	397.6	—	266.7
净利润	—	-175.5	—	-257.1	—	-334.6
自由现金流	—	-158.9	—	-220.5	—	-205.4
股份数	—	—	—	—	—	—
债务	—	—	—	—	—	—
总资产	1,074.8	—	1,164.1	—	987.4	—

客户合同口径 · 营收采用客户合同口径，可能不等同于公司全部收入。

金额及股份数均以百万为单位。缺失或待核验数据不按零处理。

03 · PEER SET

同业对比

同一细分行业中市值最接近的公司

公司	市值	近250日涨跌幅	市盈率	距52周高点	波动率
PHVS法瓦里斯	US$2.4B	+60.7%	—	-10.5%	+53.7%
RCUSArcus Biosciences, Inc.	US$2.4B	-4.6%	—	-40.1%	+61.6%
IMNMImmunome Inc.	US$2.4B	+31.8%	—	-31.9%	+61.4%
NAMS新阿姆斯特丹制药	US$2.4B	-45.5%	—	-52%	+52.8%

同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。